Koers Cannassure Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Aandelen
CSURE
IL0001110134
Gezondheidszorgvoorzieningen & -diensten
Omzet 2022 | 33,78 125,16 31,39 | Omzet 2023 | 11 40,75 10,22 | Marktkapitalisatie | 4 mln. 14,82 mln. 3,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -5 mln. -18,52 mln. -4,65 mln. | Nettowinst (verlies) 2023 | -1 mln. -3,7 mln. -929K | EV/omzet 2022 | 1.023.292 x |
Nettoschuld 2022 | 29,96 mln. 111 mln. 27,84 mln. | Nettoschuld 2023 | 434K 1,61 mln. 403K | EV/omzet 2023 | 403.186 x |
K/w-verhouding 2022 |
-0,84
x | K/w-verhouding 2023 |
-2,24
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 81,66% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 31-03-22 |
Nir Peles
CHM | Chairman | 51 | 04-12-18 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 26-06-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 04-12-18 |
Nir Peles
CHM | Chairman | 51 | 04-12-18 |
Varda Kalal
BRD | Director/Board Member | 56 | 14-02-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+47,74% | 289 mln. | |
+30,93% | 270 mln. | |
+48,84% | 193 mln. | |
-14,29% | 145 mln. | |
+57,96% | 143 mln. | |
+147,89% | 141 mln. | |
-7,69% | 80,17 mln. | |
+150,00% | 75,33 mln. | |
+43,75% | 66,15 mln. |